The TNF-α levels were reduced in the culture supernatant after CRC cells were pretreated with decreasing concentrations of rutaecarpine, indicating that rutaecarpine might block the activity of extracellular TNF-α, verifying the conclusion of the molecular docking data (Fig. 5D). The gene discussed is TNF; the disease is colorectal carcinoma.